Legal Representation
Attorney
Cynthia Walden
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Sep 23, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Sep 23, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Feb 14, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 13, 2024 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Feb 13, 2024 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Feb 13, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 22, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 21, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Aug 15, 2023 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Aug 21, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 15, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 17, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 15, 2023 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| Feb 15, 2023 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| Feb 15, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 3, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 1, 2022 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Aug 1, 2022 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Aug 1, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Jun 8, 2022 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jun 8, 2022 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jun 8, 2022 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jun 8, 2022 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jun 8, 2022 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Feb 19, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Feb 17, 2022 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Feb 17, 2022 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Feb 17, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Aug 17, 2021 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 22, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 22, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Jun 2, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 19, 2021 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 19, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| May 19, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 19, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| May 19, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| May 19, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 19, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 17, 2021 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 9, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 8, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jan 8, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Jan 8, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 4, 2021 | ZZZX | Z | PREVIOUS ALLOWANCE COUNT WITHDRAWN | Loading... |
| Dec 29, 2020 | PBCR | Z | WITHDRAWN FROM PUB - OG REVIEW QUERY | Loading... |
| Dec 15, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Dec 14, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 14, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 14, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations and substances containing rivoceranib for the treatment of cancer
Class 042
Development of therapeutics for the treatment of cancer containing rivoceranib
Additional Information
Design Mark
The mark consists of the stylized upper-case wording "TULVEGIO" above the stylized lowercase wording "RIVOCERANIB". To the left of the letter "T" is the stylized design of a hand tilted toward the letter "T".
Color Claim
Color is not claimed as a feature of the mark.
Translation
The wording "TULVEGIO RIVOCERANIB" has no meaning in a foreign language.
Classification
International Classes
005
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"RIVOCERANIB"